arrow
L

Lynette M. Sholl

brigham and women s hospital
H指数:97
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma

作者更正:揭示LINE-1在肺腺癌进化中的作用

Nature
IF48.5
2026-08-110
PRE
CLTR-08 TREATMENT STRATEGIES IN METASTATIC BREAST CANCER PATIENTS WITH LEPTOMENINGEAL DISEASE – A PROSPECTIVE OBSERVATIONAL REGISTRY STUDY

CLTR-08 治疗伴有软脑膜疾病的转移性乳腺癌患者的策略——一项前瞻性观察性登记研究

2026-08-070
OA
Contrastive learning enhances fairness in pathology artificial intelligence systems

对比学习增强了病理人工智能系统的公平性

2025-12-160
OAAI
Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations

从不吸烟者中940肺癌的微生物组分析显示缺乏临床相关关联

2025-12-120
OA
Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma

揭示LINE-1在肺腺癌进化中的作用

Nature
IF48.5
2025-12-100
PRE
Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: A joint SITC and INMC effort

病理反应新辅助评分的更新的全肿瘤指南: SITC和INMC的联合努力

2025-11-040
PRE
Brief Report: Critical Role for DNA-Based Sequencing in Discriminating Distinct Primary Lung Cancers with Different MET Exon 14 Skipping Mutations.

简报:DNA测序在区分具有不同MET外显子14跳跃突变的不同原发性肺癌中的关键作用。

2025-09-200
PRE
Clinical Implementation of Matched Tumor/Germline Sequencing Improves Accuracy of Tumor Genomic Profiling and Therapeutic Recommendations

匹配的肿瘤/体细胞测序的临床实施提高了肿瘤基因组分析准确性及治疗建议的准确性

2025-07-220
PRE
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer

分子肿瘤委员会:国际肺癌研究协会的共识声明

2025-07-070
PRE
The mutagenic forces shaping the genomes of lung cancer in never smokers

在从不吸烟者中塑造肺癌基因组的诱变力

Nature
IF48.5
2025-07-020
PRE
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small cell lung cancer

DNA甲基转移酶3A(DNMT3A)突变与非小细胞肺癌中PD-(L)1阻断疗法的疗效

2025-06-180
PRE